Prepregnancy Phenotype and Physiological Characteristics in Polycystic Ovary Syndrome

    January 2020
    Prepregnancy Phenotype, Physiological Characteristics in PCOS.Tendai M. Chiware, Carole McBride, Elizabeth A. McGee, Gary J. Badger, Ira Bernstein Md . Obstetrics, Medical Biostatistics, Vermont
    TLDR Women with PCOS have different body composition and some metabolic differences compared to healthy women.
    In a study involving 118 young women, of which 15 self-reported a diagnosis of Polycystic Ovary Syndrome (PCOS), researchers investigated subclinical metabolic and cardiovascular features. The study assessed body composition using DEXA scans, fitness through VO2 max testing, and various physiological responses including blood pressure, pulse wave speed, and hemodynamics of different organs. Blood counts, metabolic and lipid profiles were also evaluated, and HOMA-IR was calculated as an index of insulin resistance. The results indicated that women with PCOS had higher Body Mass Index (BMI), total fat, and fat distribution, as well as differences in renal and hepatic volumetrics and certain laboratory markers compared to healthy subjects. However, there were no significant differences in adrenergic response, plasma volume, blood pressure, vascular compliance, uterine blood flow, pulse wave speed, and lipid profile between the two groups. Angiotensin II, urinary sodium, and creatinine levels were statistically different. Fasting glucose, insulin, and HOMA-IR were higher in the PCOS group, though not all were statistically significant. Despite the small sample size, the study suggests that the physiology of women with PCOS differs from healthy women, which may explain the clinical trajectories and future health risks associated with PCOS.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Related Research

    2 / 2 results